Target intelligence / Profile preview

2-oxopropyl-CoM reductase (carboxylating) (2-KPCC)

Target
2-KPCC
Molecular classification
Enzyme, Oxidoreductase (specifically acts on sulfur group of donors with NAD+ or NADP+ as acceptor)
01

Overview

2-oxopropyl-CoM reductase (carboxylating) (abbreviated 2-KPCC) is a bacterial oxidoreductase enzyme, formally classified under EC 1.8.1.5, that catalyzes the conversion of 2-oxopropyl-coenzyme M (2-oxopropyl-CoM) to acetoacetate, free coenzyme M, and NADPH. It is a member of the NADPH:disulfide oxidoreductase family, which includes glutathione reductase and thioredoxin reductase, but is unique in its ability to mediate both reductive cleavage of a thioether bond and subsequent carboxylation. This enzyme participates in the microbial pathway for catabolism of propylene in species like Xanthobacter autotrophicus, but has no known therapeutic, disease-modifying, or biomarker role in human health or disease. Its structure reveals an FAD-containing, DSOR-family fold with an adapted active site specialized for its unique chemistry[1][2][3][4][8].

Other names
NADPH:2-(2-ketopropylthio)ethanesulfonate oxidoreductase/carboxylaseNADPH:2-ketopropyl-coenzyme M oxidoreductase/carboxylase2-mercaptoethanesulfonate, acetoacetate:NADP+ oxidoreductase (decarboxylating)2-ketopropyl-CoM oxidoreductase/carboxylase
02

Mechanism of action

Catalyzes reductive cleavage of thioether linkage in 2-oxopropyl-CoM, then carboxylates the cleavage product to yield acetoacetate and free coenzyme M[2][3][8]

03

Biological functions

Aliphatic epoxide carboxylationReductive cleavage of thioether bond in 2-oxopropyl-CoMPropylene catabolic processCell redox homeostasis
04

Disease associations

Other (no established role in human diseases; primarily studied in bacterial metabolism)
05

Interacting drugs

Flavin adenine dinucleotide

1 more in the full profile.

Beyond the preview

Go deeper on 2-oxopropyl-CoM reductase (carboxylating) (2-KPCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-oxopropyl-CoM reductase (carboxylating) (2-KPCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call